Side effects associated with the use of this medication such as slight nausea, constipation, and headaches were reported by some users but could usually be managed if instructions given by healthcare professionals were followed properly at all times
Formulation: Tirzepatide 10 mg/mL + Levocarnitine 100 mg/mL Schedule: Weeks 1 to 4: 2.5 mg tirzepatide (25 units) once weekly, delivering 25 mg levocarnitine Weeks 5 to 8: 5 mg tirzepatide (50 units) once weekly, delivering 50 mg levocarnitine Weeks 9 to 12: 7.5 mg tirzepatide (75 units) once weekly, delivering 75 mg levocarnitine Weeks 13+: 10 mg tirzepatide (100 units) once weekly, delivering 100 mg levocarnitine, with potential titration to 12.5 mg or 15 mg based on response and tolerability Supporting measures: Protein intake: 0.7 to 1.0 g per pound of body weight daily Resistance training: 3 to 4 sessions per week minimum Hydration: minimum 64 oz water daily Monitor body composition (not just scale weight) monthly Protocol 2: Enhanced fat oxidation for active researchers Goal: Maximize fatty acid oxidation capacity during concurrent exercise programs
Aryl Hydrocarbon Receptor (AhR): The aryl hydrocarbon receptor (AhR) pathway plays a crucial role in macrophage activation in CKD
Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG
[38] NCBI Bookshelf
